iRhythm (IRTC) Form 144 Filing Shows Insider Sale of 653 Shares
Rhea-AI Filing Summary
iRhythm Technologies, Inc. (IRTC) Form 144 notice: An individual proposes to sell 653 shares of Common stock on or about 08/22/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filing reports an aggregate market value of $109,129.36 and total shares outstanding of 32,127,763. The seller previously sold 1,608 shares on 06/02/2025 for gross proceeds of $225,457.68. Acquisition details for the 653 shares show three lots: 400 restricted shares acquired 06/01/2024, 129 ESPP shares 05/31/2023, and 124 ESPP shares 11/30/2022.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Section 144 notice disclosing a planned sale of restricted and ESPP shares; no new operational or financial information.
The filing is a standard Rule 144 notice indicating planned disposal of 653 common shares via a broker on NASDAQ. The lots consist of restricted stock and employee purchase plan shares acquired between 2022 and 2024. A prior sale of 1,608 shares in June 2025 is disclosed, showing recent liquidity by the holder. This document provides transparency about insider or control-party selling activity but contains no revenue, earnings, or forward-looking company metrics.
TL;DR: Disclosure aligns with compliance expectations; no indication of undisclosed material information by the seller.
The signer affirms they are unaware of undisclosed material adverse information, and the notice includes acquisition dates, payment methods, and recent sales as required. The mix of restricted stock and ESPP shares is typical for employee holdings. From a governance perspective, the filing documents adherence to Rule 144 disclosure requirements and provides investors with information about insider share movements without revealing company-sensitive operational details.